Researchers evaluated the impact of different treatment modalities in the prevention of psoriatic arthritis (PsA). Biological agents were found more effective than methotrexate in preventing psoriatic ...

Please provide your email address to receive an email when new articles are posted on . First-line biparametric MRI testing increased the number of biopsies and overdiagnoses vs. first-line PSA ...

(HealthDay News) — Highly conservative use of the prostate-specific antigen (PSA) test and biopsy referral is necessary for PSA screening to be cost-effective, according to a study published online ...

Risankizumab is an effective treatment option for patients with psoriatic arthritis (PsA), according to a recent meta-analysis. Risankizumab showed superior efficacy across multiple outcomes compared ...

A research team from the Department of Surgery and the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has demonstrated that ...

For patients with psoriatic arthritis, bimekizumab was more effective for treating cutaneous symptoms compared with many other available treatments and ranked highly among currently approved ...

Treatment with apremilast proved safe and effective over a 48-week period for the management of early oligoarticular psoriatic arthritis. Apremilast (APR) shows significant efficacy and safety over 48 ...

(HealthDay News) — From an economic perspective, first-line prostate-specific antigen (PSA) testing is favored over biparametric magnetic resonance imaging (bpMRI) for prostate cancer screening, ...

A study by the Comprehensive Cancer Center Vienna of MedUni Vienna and Vienna General Hospital has taken a closer look at the effectiveness of common examination methods for the early detection of ...